# ðŸ‘‹ Hi, I'm Jonathan To!

<!--
**JonathanTo99/JonathanTo99** is a âœ¨ _special_ âœ¨ repository because its `README.md` (this file) appears on your GitHub profile.
-->

## ðŸ”¬ About Me

I'm a microbiology student at BYU graduating in April 2026 with a passion for **oncolytic virotherapy** and translational cancer research. My goal is to bridge the gap between clinical diagnostics, computational biology, and cutting-edge cancer immunotherapy research to help develop more effective treatments for cancer patients.

---

## ðŸ”­ I'm currently working on

- **Finishing my BS in Microbiology** at BYU (graduating April 2026)
- **Undergraduate research** in immunology, virology, and molecular biology (MMBIO 294R, 399R, CHEM 297R)
- Building expertise in **flow cytometry** and immunology lab techniques
- Completing key courses: **Hematology**, **Immunology Lab**, and **Bioinformatics**
- Planning my transition to a **Medical Laboratory Scientist (MLS)** role in Utah

---

## ðŸŒ± I'm currently learning

- **Cancer biology & immunology** - Reading Nature Immunology, Nature Cancer, and key textbooks like *Oncoimmunology*
- **Python & R programming** for genomic data science (Coursera specializations)
- **Bioinformatics fundamentals** - preparing for future computational cancer research
- **Organic chemistry & biochemistry** - strengthening prerequisites for PhD programs
- **Data science & machine learning** - building computational skills to complement wet lab expertise

---

## ðŸŽ¯ My Career Journey

I'm on a unique path combining **clinical laboratory science**, **data science**, and **translational research**:

1. **Phase 1 (2026-2027)**: Work as MLS while completing chemistry prerequisites and professional certifications (Phlebotomy CPT, BLS, AMT MLS)
2. **Phase 2 (2028-2029)**: Pursue **MS in Data Science** at University of Pittsburgh (part-time) while continuing MLS work - focusing on cancer genomics and computational biology
3. **Phase 3 (2030)**: Apply to **PhD programs** in Cancer Biology/Virology/Immunology at institutions like Mayo Clinic, University of Pittsburgh, City of Hope, and Utah/Huntsman Cancer Institute
4. **Phase 4 (2030-2035/36)**: Complete **PhD focused on oncolytic virotherapy** - engineering viruses to target and destroy cancer cells
5. **Phase 5 (2036+)**: Lead **oncolytic virus R&D programs** in biotech/pharma while teaching as an **adjunct professor**

---

## ðŸ‘¯ I'm looking to collaborate on

- **Undergraduate research projects** in virology, immunology, or cancer biology
- **Open-source bioinformatics tools** for genomic data analysis
- **Cancer research initiatives** that bridge computational and experimental approaches
- **Educational resources** for students pursuing non-traditional paths to PhD programs

---

## ðŸ¤” I'm looking for help with

- **Networking with scientists** working in oncolytic virotherapy or cancer immunology
- **Advice on PhD applications** from people who took non-traditional paths (industry experience before PhD)
- **Bioinformatics project ideas** that could strengthen my computational biology skills
- **Mentorship** from translational scientists who bridge clinical and research worlds

---

## ðŸ’¬ Ask me about

- **Career planning** for non-traditional paths to PhD programs
- **Balancing work and graduate school** (I'll be doing MS part-time while working full-time!)
- **Medical laboratory science** as a foundation for translational research
- **Oncolytic virotherapy** and cancer immunology (my passion!)
- **Flow cytometry** and immunology lab techniques
- **Building a sustainable timeline** for long-term academic/career goals

---

## ðŸ“« How to reach me

- ðŸ’¼ **LinkedIn**: [Connect with me on LinkedIn](https://www.linkedin.com/in/jonathan-to)
- ðŸ“§ **Email**: [jonathan.to@example.com](mailto:jonathan.to@example.com)
- ðŸ§¬ **GitHub**: You're already here! Feel free to explore my projects and repositories

---

## ðŸ˜„ Pronouns

He/Him

---

## âš¡ Fun facts

- ðŸŽ“ I'll hold **4 professional certifications** by age 28: AMT MLS, Phlebotomy CPT, BLS, and First Aid
- ðŸ”¬ I'm building a **clinical-computational-research triple threat** skillset that very few scientists have
- ðŸ“Š I created an **interactive Jupyter notebook** to visualize and track my entire 10-year career roadmap with adjustable timelines and financial projections
- ðŸ§˜ I believe **sustainability > speed** - my roadmap includes detailed self-care strategies because burnout prevention is just as important as academic excellence
- ðŸŽ¯ By the time I finish my PhD, I'll have **~4 years of clinical MLS experience** + **MS in Data Science** + **research expertise** - positioning me uniquely for translational oncolytic virus research
- ðŸŒ± I'm passionate about **mentoring students from non-traditional backgrounds** who want to pursue research careers

---

## ðŸ§¬ My Unique Approach

Most PhD candidates choose one of these paths:
- **Traditional route**: BS â†’ PhD directly (age 22-28)
- **Clinical route**: BS â†’ clinical work â†’ maybe PhD later
- **Computational route**: BS â†’ MS in Bioinformatics â†’ PhD

**My hybrid approach**: 
- **BS Microbiology** â†’ **MLS work + Chemistry prerequisites** â†’ **MS Data Science** (while working) â†’ **PhD in Oncolytic Virotherapy** â†’ **Industry R&D Leadership + Adjunct Teaching**

This gives me clinical diagnostic expertise, computational biology skills, AND research training - the perfect combination for developing therapies that actually make it from the bench to the bedside! ðŸš€

---

## ðŸ“š Current Projects

Check out my repositories for:
- **Career Roadmap Tools**: Interactive Jupyter notebooks for visualizing long-term career timelines
- **Bioinformatics Learning**: Projects from my journey learning Python, R, and computational biology
- **Research Notes**: Documentation of my learning in cancer biology, virology, and immunology

---

*"The best time to plant a tree was 20 years ago. The second best time is now."* - Chinese Proverb

I'm planting my tree now at age 26, and I'm excited to see it grow into a career advancing oncolytic virotherapy research! ðŸŒ³ðŸ”¬
